Human embryonic stem cells: origins, characteristics and potential for regenerative therapy

Transfusion Medicine - Tập 18 Số 1 - Trang 1-12 - 2008
Joanne C. Mountford1
1Experimental Haematology, University of Glasgow and Scottish National Blood Transfusion Service, ATMU, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.

Tóm tắt

summary Stem cells and their use in regenerative therapies are currently hot topics in both biology and medicine. For transfusion scientists the concept of cell therapy is not a new idea but rather a fundamental practice in this field. Bone marrow transplantation was pioneered in the 1960s and relies on the capacity of haemopoietic stem cells in the donated bone marrow to completely reconstitute the blood system of the recipient. Although this capacity of adult (or somatic) stem cells to regenerate the tissue from which they arise is extremely important, the isolation and cultivation of human embryonic stem cells (hESCs) have opened up the possibility to generate any cell or tissue of the body. This characteristic of hESC offers the hope of cell replacement and regenerative therapy for a whole array of diseases, many of which are currently untreatable. However, in order to understand the potential advantages and disadvantages of using stem cells in regenerative medicine, it is necessary to fully understand their origin, characteristics and potential. This review will concentrate particularly on hESCs and their derivation, characterization and capacity to differentiate into clinically useful tissue including haemopoietic lineages.

Từ khóa


Tài liệu tham khảo

10.1634/stemcells.2006-0516

10.1016/j.tox.2006.11.060

Al‐Hajj M, 2007, Cancer stem cells and oncology therapeutics, Current Opinion in Oncology, 19, 61, 10.1097/CCO.0b013e328011a8d6

Amit M., 2006, Maintenance of human embryonic stem cells in animal serum‐ and feeder layer‐free culture conditions, Methods in Molecular Biology, 331, 105

10.1055/s-2006-954939

10.1089/scd.2006.15.729

10.1016/j.mce.2006.03.034

10.1196/annals.1392.007

10.1111/j.1432-0436.2006.00149.x

10.1111/j.1423-0410.2006.00823.x

10.1161/01.RES.0000257776.05673.ff

10.1046/j.1460-9568.2002.02255.x

10.1165/rcmb.2004-0079RC

10.1016/j.jsb.2006.11.009

10.1038/nbt1259

10.1517/14712598.6.6.551

10.1634/stemcells.2006-0130

10.1016/j.biomaterials.2007.01.021

10.1089/clo.2006.8.319

10.4161/cc.2.2.292

10.1634/stemcells.2006-0105

10.1634/stemcells.2006-0053

10.1093/oxfordjournals.humrep.a137173

10.1080/08820530590921846

10.1089/clo.2006.0045

10.1161/01.RES.0000080317.92718.99

Helg C., 1994, Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation, Transplantation, 58, 1420

10.1634/stemcells.2005-0080

10.1017/S1462399405009804

10.1089/ten.2006.12.665

10.1634/stemcells.2006-0562

10.1089/scd.2006.0010

Kennedy M., 2006, Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures, Blood, 109, 2679, 10.1182/blood-2006-09-047704

10.1038/nature05142

10.1016/j.exphem.2005.06.004

10.1083/jcb.200608162

10.1038/nbt1063

10.1371/journal.pbio.0040121

10.1089/089771504323004539

10.1097/MOH.0b013e3281900edd

10.1046/j.1469-7580.2002.00031.x

10.1161/01.CIR.0000068356.38592.68

10.1002/glia.20127

10.1111/j.1440-1681.2006.04397.x

10.1016/j.exphem.2006.07.003

10.1055/s-2006-952153

10.1038/mt.sj.6300125

10.1126/science.282.5391.1145

10.1634/stemcells.2005-0340

10.1634/stemcells.2006-0326

10.1210/er.2005-0016

10.1182/blood-2006-02-003327

10.1016/j.exphem.2005.06.002

10.1038/nbt1287

10.1152/physrev.00054.2003

10.1038/nmeth744

10.1038/ng1973

10.1634/stemcells.22-6-925

10.1016/j.neuroscience.2006.09.017

Zhang S.C., 2007, Human embryonic stem cells for brain repair?, Philosophical Transactions of the Royal Society of London. Series B: Biological Science, 23

10.1634/stemcells.2006-0377

10.1038/sj.cr.7310080

Thông tin
Thông tin xuất bản

Transfusion Medicine

Tập 18 Số 1

1-12

Thông tin tác giả